Schedule of events (Day counted from the first visit, Day 0) | Screening: visit 1 (Day −15) | Baseline, enrolment, randomization: visit 2(Day 0) | Treatment: visit 3 day 30 | Treatment visit 4 day 60 | Treatment visit 5 day 90 | Washout 1 month | Treatment visit 6 day 150 | Treatment visit 7 day 180 | Treatment visit 8 day 210 |
---|---|---|---|---|---|---|---|---|---|
Study procedures | |||||||||
Informed consent form | X | ||||||||
Medical history | X | ||||||||
Physical examination including weight and height measurements | X | ||||||||
Demographic data | X | ||||||||
Intervention | |||||||||
Control/Intervention group I (ASA in the morning and placebo in the evening in the first period) | X | X | X | Crossover | X | X | X | ||
Intervention/Control group II (placebo in the morning and ASA in the evening in the first period) | X | X | X | X | X | X | |||
Blood chemistry | |||||||||
Haematology and biochemistry | X | X | |||||||
Efficacy measures | |||||||||
ABPM | X | X | X | ||||||
Safety assessment | X | X | X | X | X | X |